Critical Advances in the Evolving Science and Medicine of STEMI Management and High-Risk ACS

Critical Advances in the Evolving Science and Medicine of STEMI Management and High-Risk ACS Addressing the Triple Threat of Mortality, Ischemia, and Bleeding in the Cardiac Catheterization Laboratory Orlando, FL
Select Session click below to choose a session for viewing for webcast help click here

Challenging the Conventional Wisdom for STEMI and High-Risk ACS Care in the Catheterization Laboratory-Moving into a New Era of Interventional Care Sunil V. Rao, MD (Program Chairman)

Advances and Uncertainties in Managing Acute Coronary Syndrome (ACS)-Connecting Evidence Across All the Trials and Streams: Why Bleeding, Mortality, and Ischemia Matter Sunil V. Rao, MD

ST-Elevation Myocardial Infraction (STEMI): Focusing on Mortality and Attributable Death Analysis in the Primary PCI Setting-What Do Landmark Drug and Device Trials Teach Us? Gregg W. Stone, MD

STEMI: Controversies, Guidelines, and Applications-Thrombus Aspiration, Choice of Stents, Access Site, and Pharmacologic Approaches to Antithrombotic Management Prof. Dr. Christian Hamm, MD

Summary and Conclusions Is a Consistent and Unified Approach to STEMI Management Achievable? Prof. Philippe Gabriel Steg, MD

Question and Answer Session Faculty Panel

Addressing the Triple Threat of Mortality, Ischemia, and Bleeding in the Cardiac Catheterization Laboratory